top of page

Evidence is the bridge between innovation and adoption.

  • tiyagohil
  • Aug 7
  • 2 min read

Updated: Aug 12

ree

The NHS is deep in operational planning for 2026/27.  With constrained budgets, rising demand, and a renewed focus on models such as integrated neighbourhood health teams, NHS leaders are seeking clarity, confidence, and credibility in the voices they choose to listen to. For organisations aiming to influence these stakeholders in an increasingly noisy policy environment, strong evidence bases and new insights are not just a strategic advantage, they are a necessity. 


Aligning with NHS priorities 


Operational planning for 2026/27 will be shaped by national priorities including: the three shifts, reducing health inequalities, improving productivity, and delivering the NHS Long Term Health Plan. Evidence-based campaigns should be tailored to show how a proposition directly supports these goals. 


For example: 

Building Credibility and Consensus 


Campaigns that are underpinned by credible data and, where relevant, co-created with clinicians, patients, and system leaders are more likely to gain traction. They foster a sense of shared ownership and reduce resistance to the independent sector. 


Our thought leadership always has an emphasis on leadership.  Led by new data and insights that often leads into new territory and spaces (we call it the white space), it is always underpinned by stakeholder interviews, panels, or advisory boards, ensuring that the campaign not just reflects the potential, but is grounded in the realities of frontline care and leadership. 


This approach not only strengthens the message but also builds a coalition of advocates who can champion the cause within their own organisations. 


Looking Ahead 


As we move toward 2026/27, the NHS will continue to make tough decisions. ZPB specialises in helping clients craft compelling, data-driven narratives that speak the language of the NHS. Whether you're preparing for a policy launch, a service redesign, or a market access strategy, now is the time to invest in evidence. 


Because in today’s NHS, evidence isn’t just persuasive, it’s critical. 

 

 
 
 

Comments


bottom of page